Annual Total Debt
$5.91 M
-$21.60 K-0.36%
December 31, 2023
Summary
- As of February 8, 2025, SABS annual total debt is $5.91 million, with the most recent change of -$21.60 thousand (-0.36%) on December 31, 2023.
- During the last 3 years, SABS annual total debt has fallen by -$2.22 million (-27.31%).
- SABS annual total debt is now -30.63% below its all-time high of $8.52 million, reached on December 31, 2021.
Performance
SABS Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Debt
$4.52 M
-$822.50 K-15.39%
September 30, 2024
Summary
- As of February 8, 2025, SABS quarterly total debt is $4.52 million, with the most recent change of -$822.50 thousand (-15.39%) on September 30, 2024.
- Over the past year, SABS quarterly total debt has dropped by -$132.10 thousand (-2.84%).
- SABS quarterly total debt is now -46.92% below its all-time high of $8.52 million, reached on December 31, 2021.
Performance
SABS Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Debt Formula
Total Debt = Short Term Debt + Long Term Debt
SABS Total Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -0.4% | -2.8% |
| 3 y3 years | -27.3% | -22.1% |
| 5 y5 years | -22.7% | -22.1% |
SABS Total Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -30.6% | at low | -46.9% | at low |
| 5 y | 5-year | -30.6% | at low | -46.9% | -100.0% |
| alltime | all time | -30.6% | at low | -46.9% | -100.0% |
SAB Biotherapeutics Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $4.52 M(-15.4%) |
| Jun 2024 | - | $5.34 M(-2.0%) |
| Mar 2024 | - | $5.45 M(-7.7%) |
| Dec 2023 | $5.91 M(-0.4%) | $5.91 M(+27.0%) |
| Sep 2023 | - | $4.65 M(-5.1%) |
| Jun 2023 | - | $4.90 M(-10.2%) |
| Mar 2023 | - | $5.46 M(-7.9%) |
| Dec 2022 | $5.93 M | $5.93 M(+2.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $5.80 M(-4.7%) |
| Jun 2022 | - | $6.09 M(-5.0%) |
| Mar 2022 | - | $6.41 M(-24.7%) |
| Dec 2021 | $8.52 M(+4.8%) | $8.52 M(>+9900.0%) |
| Sep 2021 | - | $0.00(-100.0%) |
| Jun 2021 | - | $6.92 M(>+9900.0%) |
| Mar 2021 | - | $0.00(-100.0%) |
| Dec 2020 | $8.13 M(+6.4%) | $8.13 M |
| Dec 2019 | $7.64 M | - |
FAQ
- What is SAB Biotherapeutics annual total debt?
- What is the all time high annual total debt for SAB Biotherapeutics?
- What is SAB Biotherapeutics annual total debt year-on-year change?
- What is SAB Biotherapeutics quarterly total debt?
- What is the all time high quarterly total debt for SAB Biotherapeutics?
- What is SAB Biotherapeutics quarterly total debt year-on-year change?
What is SAB Biotherapeutics annual total debt?
The current annual total debt of SABS is $5.91 M
What is the all time high annual total debt for SAB Biotherapeutics?
SAB Biotherapeutics all-time high annual total debt is $8.52 M
What is SAB Biotherapeutics annual total debt year-on-year change?
Over the past year, SABS annual total debt has changed by -$21.60 K (-0.36%)
What is SAB Biotherapeutics quarterly total debt?
The current quarterly total debt of SABS is $4.52 M
What is the all time high quarterly total debt for SAB Biotherapeutics?
SAB Biotherapeutics all-time high quarterly total debt is $8.52 M
What is SAB Biotherapeutics quarterly total debt year-on-year change?
Over the past year, SABS quarterly total debt has changed by -$132.10 K (-2.84%)